Dr K. Anand Kumar, Managing Director, Indian Immunologicals receives FABA Lifetime Achievement Award

Dr K. Anand Kumar, Managing Director of Indian Immunologicals Limited (IIL), has been conferred with the prestigious FABA Lifetime Achievement Award by the Federation of Asian Biotech Associations (FABA), in recognition of his outstanding contributions to biotechnology, vaccine research, development and manufacturing, and the advancement of India’s human and animal healthcare sectors.

The award recognises Dr Anand Kumar’s distinguished professional journey, visionary leadership and significant contributions towards strengthening India’s vaccine ecosystem and making quality vaccines accessible and affordable. His commitment to scientific excellence, innovation and public health has played an important role in advancing India’s capabilities in biotechnology and biologicals.

Under his leadership, Indian Immunologicals Limited has continued to strengthen its position as a leading vaccine manufacturer, contributing to India’s self-reliance in vaccines for both human and animal health. The organisation has been at the forefront of developing and manufacturing vaccines that address critical public health needs, while also contributing to disease prevention, animal healthcare and food security.

Being recognised alongside such eminent leaders is a significant honour and underscores Dr Anand Kumar’s contributions to India’s biotechnology and vaccine development landscape.